Gene therapy advances continue to fill product pipelines
Recently there has been a significant resurgence in the use of gene and cell therapies thanks to improving efficiencies and safety of these methodologies. As we described in last week's issue of BioWorld Insight, with a number of gene therapies advancing into later-stage trials, the field has begun to attract significant amounts of both private and public capital investments once again.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter